These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11916361)

  • 1. Apoptosis in heart failure: a real problem?
    Sabbah HN
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):525-8. PubMed ID: 11916361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death, tissue hypoxia and the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Heart Fail Rev; 2000 Jun; 5(2):131-8. PubMed ID: 16228140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death in the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Ann Med; 1998 Aug; 30 Suppl 1():33-8. PubMed ID: 9800881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in heart failure.
    Sabbah HN; Sharov VG
    Prog Cardiovasc Dis; 1998; 40(6):549-62. PubMed ID: 9647609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytopathological basis of heart failure--cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response.
    Petrovic D
    Folia Biol (Praha); 2004; 50(2):58-62. PubMed ID: 15222127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure.
    Goussev A; Sharov VG; Shimoyama H; Tanimura M; Lesch M; Goldstein S; Sabbah HN
    Am J Physiol; 1998 Aug; 275(2):H626-31. PubMed ID: 9683452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomal analysis of failing and nonfailing human hearts.
    Steenman M; Chen YW; Le Cunff M; Lamirault G; Varró A; Hoffman E; Léger JJ
    Physiol Genomics; 2003 Jan; 12(2):97-112. PubMed ID: 12429867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
    Sabbah HN
    Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium.
    Sharov VG; Kostin S; Todor A; Schaper J; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):297-303. PubMed ID: 16583178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of apoptosis in ventricular remodeling.
    Chandrashekhar Y
    Curr Heart Fail Rep; 2005 Mar; 2(1):18-22. PubMed ID: 16036047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
    Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
    Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE; Konstam MA
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of LV systolic dyssynchrony in heart failure beyond a snapshot.
    Yu CM; Zhang Q
    JACC Cardiovasc Imaging; 2011 May; 4(5):457-9. PubMed ID: 21565731
    [No Abstract]   [Full Text] [Related]  

  • 18. Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism.
    Consoli C; Gatta L; Iellamo F; Molinari F; Rosano GM; Marlier LN
    Int J Cardiol; 2013 Sep; 167(6):2859-66. PubMed ID: 22882964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction.
    Adamson PB; Vanoli E
    J Am Coll Cardiol; 2001 May; 37(6):1741-8. PubMed ID: 11345393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, cell death, and heart failure.
    Oyama J; Frantz S; Blais C; Kelly RA; Bourcier T
    Heart Fail Rev; 2002 Oct; 7(4):327-34. PubMed ID: 12379818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.